✓
Open
29 Sep to 4 Oct, 2017
✓
Close
29 Sep to 4 Oct, 2017
3
Allotment
—
✓
Listing
Thu, Oct 12, 2017
Price Band
₹85 per share
Issue Size
22,96,000 shares (agg. up to ₹20 Cr)
Lot Size
1,600 Shares
Listing Date
Thu, Oct 12, 2017
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 18.76x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2017 | 31 Mar 2016 | 31 Mar 2015 |
|---|---|---|---|
| Assets | 24.54 | 15.20 | 8.01 |
| Total Income | 41.68 | 26.39 | 0.26 |
| Profit After Tax | 5.18 | 1.13 | 0.11 |
| NET Worth | 7.38 | 2.20 | 1.07 |
| Reserves and Surplus | 6.37 | 1.19 | 0.06 |
| Total Borrowing | 7.52 | 7.75 | 4.37 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Shree Ganesh Remedies Ltd. | SME | ₹8.55 Cr | ₹36 | null | ₹33.00 | -8.33% | ₹696.00 |
| ANG Lifesciences India Ltd. | SME | ₹12.01 Cr | ₹80 | null | ₹96.00 | +20.00% | ₹35.10 |
| Vaishali Pharma Ltd. | SME | ₹14.23 Cr | ₹72 | null | ₹70.35 | -2.29% | ₹8.34 |
| Zota Health Care Ltd. | SME | ₹58.50 Cr | ₹125 | null | ₹125.60 | +0.48% | ₹1,113.10 |
| Sakar Healthcare Ltd. | SME | ₹14.81 Cr | ₹50 | null | ₹52.15 | +4.30% | ₹1,157.85 |
| Eris Lifesciences Ltd. | Mainboard | ₹1,740.49 Cr | ₹603 | null | ₹601.50 | -0.25% | ₹1,324.70 |
| Laurus Labs Ltd. | Mainboard | ₹1,330.51 Cr | ₹428 | null | ₹480.40 | +12.24% | ₹1,946.90 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of new plant and machinery and upgradtion of the existing plant and machinery | 7.42 |
| 2 | Civil Construction work at existing manufacturing unit. | 1.28 |
| 3 | To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme | 0.79 |
| 4 | Working Capital | 2.95 |
| 5 | General Corporate Purpose | 4.10 |
About Beta Drugs IPO
Updated on Aug 12, 2026
Contact Details
Beta Drugs Ltd. AddressVillage, NandpurBaddi, Himachal Pradesh, 1741001795-236196info@betadrugslimited.comVisit Website